Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling mtor signaling'

Search results for: 'research area pi3k akt signaling mtor signaling'

Items 41-50 of 94

Page
per page
  1. BIX 02189
    A5801 BIX 02189
    Target: MEK|ERK
    Summary: Selective MEK5 inhibitor
      ≥22.05 mg/mL
  2. GF 109203X
    A8342 GF 109203X
     1 Citation
    Target: PKC
    Summary: Protein kinase C,MLCK,PKG and PKA inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.6 mg/mL
  3. Vemurafenib (PLX4032, RG7204)
    A3004 Vemurafenib (PLX4032, RG7204)
     9 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥24.5 mg/mL
  4. NSC 74859
    A8338 NSC 74859
     5 Citation
    Target: STAT
    Summary: Stat3 inhibitor
      insoluble in H2O; ≥18.25 mg/mL
  5. Miltefosine
    B1371 Miltefosine
    Target: PI3K
    Summary: PI3K/Akt inhibitor
      ≥10.2 mg/mL
  6. GW788388
    A8301 GW788388
    Summary: ALK5 inhibitor,potent and selective
      ≥21.25 mg/mL
  7. LY2157299
    A8348 LY2157299
     2 Citation
    Summary: TGF-βR1 inhibitor,potent and selective
      insoluble in H2O; ≥18.45 mg/mL
  8. LY2109761
    A8464 LY2109761
     4 Citation
    Summary: TβRI/II kinase inhibitor
      ≥22.1 mg/mL
  9. A 83-01
    A3133 A 83-01
    Summary: ALK-5 inhibitor
      ≥21.1 mg/mL
  10. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL

Items 41-50 of 94

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Reversibility
  1. Reversible 3item
  2. Irreversible 1 item
Target
  1. Histone Deacetylases (HDACs) 1 item
  2. Akt 5item
  3. PI3K 21item
  4. Raf 6item
  5. mTOR 14item
  6. Androgen Receptors 1 item
  7. GSK-3 5item
  8. P-glycoprotein (P-gp) 1 item
  9. PLK 1 item
  10. Eph Receptors 1 item
  11. VEGFR 4item
  12. PDGFR 2item
  13. Phosphodiesterases (PDEs) 1 item
  14. p38 4item
  15. PKB 1 item
  16. JNK 2item
  17. Bcr-Abl 1 item
  18. MEK 4item
  19. PORCN 1 item
  20. FGFR 1 item
  21. GABAB Receptors 1 item
  22. Smoothened 1 item
  23. Src 1 item
  24. STAT 4item
  25. EGFR 2item
  26. Hedgehog 1 item
  27. BMP and Other Activin Receptors 2item
  28. JAK 2item
  29. Syk 1 item
  30. DNA-PK 6item
  31. HSP90 1 item
  32. TNKS 1 item
  33. Toll-like receptors (TLRs) 1 item
  34. ERK 1 item
  35. PKC 3item
  36. Melanocortin (MC) Receptors 1 item
  37. Fatty-acid-binding proteins (FABPs) 1 item
  38. ATM/ATR 1 item
  39. P110 1 item
  40. Hck 1 item
  41. NO Donors / Precursors 1 item
  42. IL Receptors 1 item
  43. PKD 1 item
  44. ATM 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 2item
  3. Bladder Cancer 1 item
  4. Breast Cancer 23item
  5. Cancer 67item
  6. Cervical Cancer 2item
  7. Cholangiocarcinoma 1 item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Colon Cancer 10item
  10. Colon Carcinoma 1 item
  11. Colorectal Cancer 11item
  12. Glioblastoma 11item
  13. Glioma 4item
  14. Hepatocellular Carcinoma 1 item
  15. Leukemia 5item
  16. Liver Cancer 1 item
  17. Lung Cancer 7item
  18. Lymphoma 2item
  19. Melanoma 6item
  20. Multiple Myeloma 1 item
  21. Myeloma 1 item
  22. Neuroblastoma 2item
  23. Non-small Cell Lung Cancer 6item
  24. Ovarian Cancer 7item
  25. Pancreatic Cancer 10item
  26. Pancreatic Carcinoma 2item
  27. Prostate Cancer 11item
  28. Pulmonary Arterial Hypertension 1 item
  29. Pulmonary Fibrosis 1 item
  30. Renal Cancer 2item
  31. Rheumatoid Arthritis 2item
  32. Thyroid Cancer 2item
  33. Type 2 Diabetes 2item